Literature DB >> 17188816

Precipitants of first substance use in recently abstinent substance use disorder patients with PTSD.

Paige Ouimette1, Deborah Coolhart, Jennifer Schum Funderburk, Michael Wade, Pamela J Brown.   

Abstract

Patients with substance use (SUD) and posttraumatic stress disorders (PTSD) are at high risk for relapse. This study examined the reasons patients identify for their first substance use following discharge from SUD treatment. A total of 65 patients with and without PTSD completed clinical interviews, including an adapted version of the Relapse Interview [RI; Miller, W.R., & Marlatt, G.A. (1996). Appendix A: Relapse Interview. Addiction, 91(Suppl), 231-240.] at a 6-month follow-up. Qualitative data from the RI was consensus coded using Marlatt's taxonomy of relapse situations. Results indicated that patients with PTSD were less likely to report first substance use triggered by cue-based urges and more likely to report use in response to negative emotions of an interpersonal nature than those patients without PTSD. Other characteristics of first use associated with PTSD included greater subjective urges right before using, greater efforts to obtain substances and more likelihood to use to intoxication. Patients with unremitted PTSD reported poorer outcome and self-efficacy expectations than those without PTSD or with remitted PTSD. Implications for self-medication theory and clinical practice are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 17188816     DOI: 10.1016/j.addbeh.2006.11.020

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  40 in total

Review 1.  Epidemiology and management of alcohol dependence in individuals with post-traumatic stress disorder.

Authors:  Elissa McCarthy; Ismene Petrakis
Journal:  CNS Drugs       Date:  2010-12       Impact factor: 5.749

Review 2.  Substance use modulates stress reactivity: Behavioral and physiological outcomes.

Authors:  Anne Q Fosnocht; Lisa A Briand
Journal:  Physiol Behav       Date:  2016-02-19

3.  Disruption of glutamate receptor-interacting protein in nucleus accumbens enhances vulnerability to cocaine relapse.

Authors:  Lisa A Briand; Blake A Kimmey; Pavel I Ortinski; Richard L Huganir; R Christopher Pierce
Journal:  Neuropsychopharmacology       Date:  2013-10-15       Impact factor: 7.853

4.  Posttraumatic stress symptoms and alcohol problems: self-medication or trait vulnerability?

Authors:  Jennifer P Read; Jennifer E Merrill; Melissa J Griffin; Rachel L Bachrach; Saba N Khan
Journal:  Am J Addict       Date:  2013-06-10

5.  The influence of posttraumatic stress disorder and recurrent major depression on risk-taking propensity following trauma script exposure among patients with substance use disorders.

Authors:  Ariana G Vidaña; Courtney N Forbes; Kim L Gratz; Matthew T Tull
Journal:  Addict Behav       Date:  2019-10-24       Impact factor: 3.913

6.  Do PTSD symptoms and course predict continued substance use for homeless individuals in contingency management for cocaine dependence?

Authors:  Michelle Nicole Burns; Kenneth A Lehman; Jesse B Milby; Dennis Wallace; Joseph E Schumacher
Journal:  Behav Res Ther       Date:  2010-03-16

7.  Not all stress is equal: CREB is not necessary for restraint stress reinstatement of cocaine-conditioned reward.

Authors:  Lisa A Briand; Julie A Blendy
Journal:  Behav Brain Res       Date:  2013-03-01       Impact factor: 3.332

Review 8.  Molecular and genetic substrates linking stress and addiction.

Authors:  Lisa A Briand; Julie A Blendy
Journal:  Brain Res       Date:  2009-11-10       Impact factor: 3.252

9.  The effect of posttraumatic stress disorder on risk-taking propensity among crack/cocaine users in residential substance abuse treatment.

Authors:  Matthew T Tull; Adria Trotman; Michelle S Duplinsky; Elizabeth K Reynolds; Stacey B Daughters; Marc N Potenza; C W Lejuez
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

10.  Effect of traumatic event reexposure and PTSD on substance use disorder treatment response.

Authors:  Jessica M Peirce; Robert K Brooner; Van L King; Michael S Kidorf
Journal:  Drug Alcohol Depend       Date:  2015-11-21       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.